Latest News

  • Stem cell therapy improves frailty mobility

    A stem cell therapy improved mobility in older adults with age-related frailty after nine months in a phase 2b trial, compared with placebo. Frailty is a condition in which older people become less able to cope with everyday or sudden stress, leaving them more vulnerable to illness, injury and poor outcomes after surgery. The study [...]

  • Agetech investment and innovation round-up

    Global market to hit US$740bn in 2026, longevity needs lifts? ‘little brain’s’ big role, ageing ethics questioned…and more IRISH insight and analysis company Research and Markets estimates the global ageing economy will surpass US$740bn this year. These projections by the company, which is based next to the Guinness Brewery in Dublin, come in its latest [...]

  • Obstructive sleep apnoea costs UK and US economies £137bn a year, study finds

    Sleep apnoea costs the UK and US economies more than £137bn a year, with researchers calling for workplace screening and earlier treatment. The condition causes repeated pauses in breathing during sleep. People often snore loudly, wake gasping for air and experience severe daytime tiredness. If untreated, it raises the risk of heart attack and stroke. [...]

  • Nyra health raises €20m for digital neurotherapy

    Nyra health has raised €20m to scale its digital neurotherapy platform for neurological rehabilitation, targeting conditions such as stroke and dementia. The Series A funding will be used to expand the company’s technology across the DACH region, accelerate its expansion into the US and support a more data-driven approach to neurorehabilitation. Founded in 2021, Vienna-based [...]

  • Centenarians’ blood reveals longevity clues

    Centenarians’ blood contains 37 proteins linked to slower ageing, with profiles closer to younger adults than to octogenarians, according to new research. In Switzerland, around 0.02 per cent of the population lives beyond 100. As part of the SWISS100 project, researchers compared blood samples from centenarians, octogenarians and adults aged 30 to 60 to identify [...]

  • Interview: The US company appealing Europe’s rejection of daily Alzheimer’s pill

    Despite having its application for a new, daily Alzheimer’s pill rejected by Europe’s regulators the CEO of US drug company Anavex Life Sciences is appealing this decision. A Phase IIb/III trial  found over one-third of patients with mild Alzheimer’s - those with a Mini-Mental State Examination (MMSE) score of between 20 and 28 - experienced [...]

  • US$80m backs exceptional longevity study

    NIH funding of US$80m will support further research into exceptional longevity, continuing a long-running study of families whose members live far longer than statistical models predict. The funding renews support for the Long Life Family Study, an international project tracking multiple generations, including people who have lived to 100 and beyond. Researchers are seeking genetic [...]

  • CBS News cuts ties with Peter Attia

    CBS News has cut ties with Peter Attia after initial resistance, following revelations that his name appears more than 1,700 times in files linked to convicted paedophile Jeffrey Epstein. Attia, a physician specialising in longevity medicine, was among 19 contributors named last month by CBS News editor in chief Bari Weiss. A CBS News executive [...]

  • Astellas and Vir strike prostate cancer deal

    Astellas has agreed a US$1.7bn global prostate cancer deal with Vir Biotechnology to develop a masked T-cell engager designed to harness the immune system against the disease. The collaboration centres on VIR-5500, a PSMAxCD3 bispecific drug known as a T-cell engager, or TCE. TCEs activate immune cells called T cells and direct them to attack [...]

  • Human liver rebuilt in 3D

    Human liver tissue has been reconstructed in 3D at a cellular level, revealing how cirrhosis alters the organ’s internal structure compared with healthy tissue. The 3D reconstructions capture the fine-scale microstructure of multiple liver lobes and show how scarring disrupts biological activity inside the organ. Cirrhosis is extensive scarring of the liver caused by long-term [...]